Picture of Dyne Therapeutics logo

DYN — Dyne Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

Brief: Dyne Therapeutics Announces New Positive Cardiopulmonary Results From Deliver Trial Of Z-Rostudirsen In Duchenne Muscular Dystrophy (Dmd)

Dyne Therapeutics Inc DYN.O:

DYNE THERAPEUTICS ANNOUNCES NEW POSITIVE CARDIOPULMONARY RESULTS FROM DELIVER TRIAL OF Z-ROSTUDIRSEN IN DUCHENNE MUSCULAR DYSTROPHY (DMD)

DYNE THERAPEUTICS INC - 24-MONTH DATA SHOW IMPROVED HEART AND LUNG FUNCTION WITH Z-ROSTUDIRSEN IN DMD

Source text: ID:nGNX1L34ZK

Further company coverage: DYN.O

Recent news on Dyne Therapeutics

See all news